04.02.13
EOS Imaging, a provider of orthopedic imaging technology, has gained 510(k) clearance from the U.S. Food and Drug Administration for its next-generation Stereos 3-D imaging software, the Stereos 1.5. The technology was featured last month at the annual meeting of the American Academy of Orthopaedic Surgeons in Chicago, Ill.
The Stereos software provides 3-D modeling of the spine and lower limb based on scans taken with the EOS system, and is programmed to calculate more than 100 clinical parameters relevant to diagnosis and surgical planning. The new system adds expanded calculation and analysis, with new capabilities to measure hip implant component position for surgery control and revision. The software is also designed to perform 3-D modeling of severe scoliosis (Cobb angle above 50 degrees). Stereos 1.5 will be made available to existing EOS customers as a software upgrade and will be included in all new system sales.
The EOS system is a full-body, low-dose 3-D imaging system, delivering a radiation dose claimed to be nine times lower than that of computed radiography X-ray and 20 times lower than basic CT (computed tomography) scans, according to the company.
“The introduction of hip arthroplasty post-operative 3-D imaging to the EOS System answers growing challenges in orthopedic surgery post-op evaluation,” said Marie Meynadier, CEO of EOS imaging “It also provides the first weight-bearing 3-D solution to enhance the understanding and, ultimately, treatment of total hip replacement complications such as dislocations and wear. Ongoing research supports the unique value of EOS in understanding the relation between implant position, pelvic mobility and patient function, therefore improving treatment and patient outcomes in joint arthroplasty.”
One of the first clinical applications of the new features in assessing and monitoring hip implant alignment is discussed in a paper under consideration for the Hip Society Awards, authored by Ian Clarke, Ph.D, of Loma Linda University in California and Jean-Yves Lazennec, M.D., of La Pitié Salpétrière Hospital in Paris, France. The study, titled “Impingement and Abrasion Risks with MOM [metal-on-metal] Bearings,” reviews how metal-on-metal hip prosthesis wear is related to implant component orientation.
EOS Imaging is based in Paris, France, with U.S. headquarters in Cambridge, Mass.
The Stereos software provides 3-D modeling of the spine and lower limb based on scans taken with the EOS system, and is programmed to calculate more than 100 clinical parameters relevant to diagnosis and surgical planning. The new system adds expanded calculation and analysis, with new capabilities to measure hip implant component position for surgery control and revision. The software is also designed to perform 3-D modeling of severe scoliosis (Cobb angle above 50 degrees). Stereos 1.5 will be made available to existing EOS customers as a software upgrade and will be included in all new system sales.
The EOS system is a full-body, low-dose 3-D imaging system, delivering a radiation dose claimed to be nine times lower than that of computed radiography X-ray and 20 times lower than basic CT (computed tomography) scans, according to the company.
“The introduction of hip arthroplasty post-operative 3-D imaging to the EOS System answers growing challenges in orthopedic surgery post-op evaluation,” said Marie Meynadier, CEO of EOS imaging “It also provides the first weight-bearing 3-D solution to enhance the understanding and, ultimately, treatment of total hip replacement complications such as dislocations and wear. Ongoing research supports the unique value of EOS in understanding the relation between implant position, pelvic mobility and patient function, therefore improving treatment and patient outcomes in joint arthroplasty.”
One of the first clinical applications of the new features in assessing and monitoring hip implant alignment is discussed in a paper under consideration for the Hip Society Awards, authored by Ian Clarke, Ph.D, of Loma Linda University in California and Jean-Yves Lazennec, M.D., of La Pitié Salpétrière Hospital in Paris, France. The study, titled “Impingement and Abrasion Risks with MOM [metal-on-metal] Bearings,” reviews how metal-on-metal hip prosthesis wear is related to implant component orientation.
EOS Imaging is based in Paris, France, with U.S. headquarters in Cambridge, Mass.